Julie Freischlag to Arteriovenous Shunt, Surgical
This is a "connection" page, showing publications Julie Freischlag has written about Arteriovenous Shunt, Surgical.
Connection Strength
0.836
-
Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, Schneider EB, Black JH, Segev DL, Freischlag JA. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015 May; 150(5):441-8.
Score: 0.488
-
Zarkowsky DS, Hicks CW, Arhuidese I, Canner JK, Obeid T, Qazi U, Schneider E, Abularrage CJ, Black JH, Freischlag JA, Malas MB. Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care. JAMA Surg. 2015 Aug; 150(8):764-70.
Score: 0.124
-
Zarkowsky DS, Arhuidese IJ, Hicks CW, Canner JK, Qazi U, Obeid T, Schneider E, Abularrage CJ, Freischlag JA, Malas MB. Racial/Ethnic Disparities Associated With Initial Hemodialysis Access. JAMA Surg. 2015 Jun; 150(6):529-36.
Score: 0.123
-
Barton J, Nielsen H, Rychnovsky S, Farooq M, Freischlag J, Grove R. PhotoPoint photodynamic therapy inhibits intimal hyperplasia in arteriovenous access grafts. Cardiovasc Radiat Med. 2002 Jul-Dec; 3(3-4):147-51.
Score: 0.050
-
Burgher JM, Barton JM, Farooq MM, Vasek J, Scott RW, Freischlag JA, Grove RI. PhotoPoint photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models. Cardiovasc Radiat Med. 2002 Jul-Dec; 3(3-4):163-8.
Score: 0.050